The overall objectives of this RC2, now R56, application entitled “Renal Osteodystrophy Precision Medicine Project”, are: 1. Provide RNA and ATAC sequencing of bone biosies from patients with renal osteodystrophy (ROD) 2. Determine the osseous transcriptome and epigenome in these biopsies;
|Effective start/end date||9/16/22 → 5/31/24|
- Columbia University (3(GG016514-01)//1R56DK127986-01A1)
- National Institute of Diabetes and Digestive and Kidney Diseases (3(GG016514-01)//1R56DK127986-01A1)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.